Sharon Bio-Medicine Ltd. reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported revenue was INR 449.11 million compared to INR 462.47 million a year ago. Net income was INR 40.23 million compared to INR 45.63 million a year ago. Basic earnings per share from continuing operations was INR 6.99 compared to INR 7.93 a year ago.
For the nine months, revenue was INR 1,403.04 million compared to INR 1,263.2 million a year ago. Net income was INR 129.94 million compared to INR 84.37 million a year ago. Basic earnings per share from continuing operations was INR 22.58 compared to INR 14.66 a year ago.